戻る
Hansoh Pharmaceutical Group Company Limited (03692.HK)価格
03692.HK 株価推移チャート
HANSOH PHARMA (03692.HK)
Hansoh Pharmaceutical Group Company Limited
HK$40.26
-0.54%
$-0.21
休場: Jan 22, 16:00:00 HKT
A+
最終スコア
主要データ
前終値
$40.5
始値
$40.48
当日レンジ
$40.04 - $41.2
52週レンジ
$15.96 - $44.22
取引高
4.1M
平均取引高
7.8M
1株当たり利益(TTM)
0.89
配当利回り
--
時価総額
$239.3B
HANSOH PHARMAとは何ですか？
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.